Chat with us, powered by LiveChat

Past

Genetic Toxicology Association Annual Meeting

The Genetic Toxicology Association (GTA) held its annual scientific meeting April 10-12th, in Delaware, Newark. Principal Scientist, Susanne Stalford presented a poster in collaboration with Toxys, the poster is titled ‘Association of the ToxTracker® Assay to Genotoxicity Adverse Outcome Pathways’. ToxTracker® is a next generation stem-cell based assay that utilises a combination of six unique fluorescent …

Genetic Toxicology Association Annual Meeting Read More »

8th Impurities: Genotoxic, Nitrosamine & Beyond Summit

We were delighted to attend the 8th Impurities: Genotoxic, Nitrosamine & Beyond Summit. Senior Application Scientist, Gabriela Silveira presented ‘Accelerating nitrosamine risk assessment: Meeting emerging regulatory guidelines’. In this talk, she discussed: – Use of in-silico tools on nitrosamine risk assessments – How data sharing and collaboration aid in nitrosamines assessments – Setting AIs using …

8th Impurities: Genotoxic, Nitrosamine & Beyond Summit Read More »

9th German Pharm-Tox Summit

We were delighted to attend the 9th German Pharm-Tox Summit, on March 13–15, 2024, in Munich, Germany. The GPTS is organized by the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) together with the Austrian Society of Toxicology (ASTOX), Austrian Pharmacological Society (APHAR) and the Association for Applied Human Pharmacology (AGAH). The program, …

9th German Pharm-Tox Summit Read More »

Leachables sensitisation assessment framework in collaboration with ELSIE

This enlightening event brought together esteemed members of the Extractables and Leachables Safety Information Exchange (ELSIE) consortium for a captivating discussion on the sensitisation potential of extractables and leachables (E&Ls). Featured presenters and ELSIE consortium members included: Patricia Parris, Global Risk Assessment Services Toxicologist at Pfizer Geraldine Whelan, Regulatory Toxicologist at GSK Martyn Chilton, Principal …

Leachables sensitisation assessment framework in collaboration with ELSIE Read More »

Performing ICH M7 risk assessment for process impurities and degradation products (in Spanish)

Performing ICH M7 risk assessment for process impurities and degradation products was targeted towards Latin America and carried out in Spanish. In this event, we explored how our software solution, Zeneth, can help you to identify potential degradation impurities in your drug development workflow. We also demonstrated how to classify potentially mutagenic impurities through our …

Performing ICH M7 risk assessment for process impurities and degradation products (in Spanish) Read More »

Streamlining your drug development workflow using purge calculations (in Japanese)

Join us for our webinar, Streamlining your drug development workflow using purge calculations. This webinar was hosted in Japanese and contained pre-recorded videos with Japanese subtitles. We were delighted to have Senior Principal Scientist Andy Teasdale, presenting in this webinar. Andy is currently the chair of AstraZeneca’s Impurity advisory Board, and has developed a wealth …

Streamlining your drug development workflow using purge calculations (in Japanese) Read More »

3rd annual genotoxic impurities summit: Nitrosamines & beyond 2023

The safety, quality and clinical results of drug substances and drug products may be disrupted by the formation of nitrosamines along with other mutagenic impurities. The comprehensive development and production of innovative medicines now inevitably involves estimating impurity profiles as well as managing and monitoring them. To meet the demands of ever-increasing regulatory standards and …

3rd annual genotoxic impurities summit: Nitrosamines & beyond 2023 Read More »